Insights - Celldex Therapeutics (CLDX) has climbed 100% from all-time lows this summer – 40% in the last week – on encouraging and arguably groundbreaking results from a phase II … Continue Reading
Read NowInsights - Pfizer (PFE) put up $850 million to partner with Merck KGaA on a number of immuno-oncology drugs.
Read NowInsights - Dendreon (DNDN) has filed for bankruptcy protection and reached agreement with a majority of its debtholders to convert to equity in the company.
Read NowInsights - In one of the most shocking accounting errors we’ve seen in pharma, Salix Pharmaceuticals (SLXP) reported on Thursday after the bell that it has nine months of … Continue Reading
Read NowInsights - At $14.5 million, global sales of Ariad Pharmaceuticals’ (ARIA) Iclusig (ponatinib) came in below consensus expectations for $16 million in the quarter. Though sales are up … Continue Reading
Read NowInsights - The FDA has removed a clinical hold prohibiting Geron Corp (GERN) from dosing new patients with its investigational cancer drug imetelstat, sending the company’s stock higher by 35% … Continue Reading
Read NowInsights - Synergy Pharmaceuticals (SGYP) cleared out a major overhang on Wednesday Oct. 28 – evidenced by the stock’s 15% move higher in the session – with the … Continue Reading
Read Now
